LAG3 and lung cancer: This finding is similar to Prado-Garcia et al., where 3–6% of MPE CD8+ and CD4+ T cells co-expressed PD-1+TIM-3+ or PD-1+LAG-3+ in lung cancer patients pre-treatment [38].